Skip to main content

Alpha-Defensin vs PT-141 (Bremelanotide)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Alpha-Defensin

Alpha-defensins are small cationic peptides that are key components of the innate immune system. They have broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses.

Full details →

PT-141 (Bremelanotide)

PT-141, also known as Bremelanotide, is a synthetic peptide analog of alpha-melanocyte-stimulating hormone. It is the only FDA-approved treatment for hypoactive sexual desire disorder (HSDD) in premenopausal women.

Full details →

Side-by-Side Comparison

AspectAlpha-DefensinPT-141 (Bremelanotide)
Dose Range100 mcg–500 mcg1.8 mg
Frequency1x dailyLess than daily
Cycle Length2–4 weeks4–12 weeks
Routesubcutaneoussubcutaneous
MechanismInsert into microbial membranes to form pores, leading to cell death. Also have immunomodulatory effects including chemotaxis of immune cells and cytokine modulation.PT-141 activates melanocortin receptors (MC3R and MC4R) in the central nervous system, particularly in areas associated with sexual arousal. Unlike PDE5 inhibitors, it works through the nervous system rather than the vascular system.
Typical DosageResearch compound - dosing varies by application. Typically studied in laboratory and early clinical research settings rather than for general use.FDA-approved dose: 1.75mg administered subcutaneously at least 45 minutes before anticipated sexual activity. Not to be used more than once within 24 hours or more than 8 times per month.
AdministrationVarious routes studied including topical, local injection, and systemic administration depending on application.Subcutaneous injection in the abdomen. Available as Vyleesi (commercial product). Research use may involve different dosing protocols.
Side EffectsLimited human use data. May cause local inflammation. Potential for immune activation effects.Common side effects include nausea (40% of users), flushing, headache, and injection site reactions. Transient blood pressure increases may occur.
Best For

What They Have in Common

Alpha-Defensin, PT-141 (Bremelanotide) are both commonly used for:

Key Differences

Unique to Alpha-Defensin:

Which Has Stronger Evidence?

  • Recovery & Healing: Alpha-Defensin has stronger research support.
GoalAlpha-DefensinPT-141 (Bremelanotide)
Recovery & Healingmediumlow

Key Studies

Ready to Learn More?